{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:07:31Z","timestamp":1772305651634,"version":"3.50.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.pupt.2005.10.008","type":"journal-article","created":{"date-parts":[[2005,12,19]],"date-time":"2005-12-19T15:52:07Z","timestamp":1135007527000},"page":"23-35","source":"Crossref","is-referenced-by-count":48,"title":["Safety of inhaled corticosteroids: Room for improvement"],"prefix":"10.1016","volume":"20","author":[{"given":"Giovanni A.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franklin","family":"Cerasoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2005.10.008_bib1","series-title":"Global initiative for asthma: global strategy for asthma management and prevention","year":"2004"},{"key":"10.1016\/j.pupt.2005.10.008_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/pupt.2001.0312","article-title":"Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma","volume":"15","author":"Umland","year":"2002","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2005.10.008_bib3","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0024-3205(02)02446-3","article-title":"Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases","volume":"72","author":"Pelaia","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pupt.2005.10.008_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1378\/chest.126.1.220","article-title":"Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD","volume":"126","author":"Cazzola","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2005.10.008_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1183\/09031936.04.00049604","article-title":"Inhaled corticosteroids and the risk of a first exacerbation in COPD patients","volume":"23","author":"de Melo","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(02)01143-9","article-title":"The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials","volume":"113","author":"Alsaeedi","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib7","series-title":"Pharmacotherapy in chronic obstructive pulmonary disease","first-page":"265","article-title":"Corticosteroids in COPD","author":"Cazzola","year":"2004"},{"key":"10.1016\/j.pupt.2005.10.008_bib8","first-page":"846","article-title":"Comparing inhaled corticosteroids","volume":"45","author":"Colice","year":"2000","journal-title":"Respir Care"},{"issue":"Suppl. 4","key":"10.1016\/j.pupt.2005.10.008_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-199958004-00002","article-title":"Pharmacological factors that influence the choice of inhaled corticosteroids","volume":"58","author":"Edsbacker","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2005.10.008_bib10","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1001\/archinte.162.22.2527","article-title":"Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review","volume":"162","author":"Singh","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2125.1997.d01-1425.x","article-title":"Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects","volume":"43","author":"Thorsson","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2005.10.008_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0091270003260334","article-title":"Risk\u2013benefit value of inhaled glucocorticoids: a pharmacokinetic\/pharmacodynamic perspective","volume":"44","author":"Rohatagi","year":"2004","journal-title":"J Clin Pharmacol"},{"issue":"Suppl. 39","key":"10.1016\/j.pupt.2005.10.008_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.1997.tb05047.x","article-title":"A comparison of the efficacy and safety of inhaled corticosteroids in asthma","volume":"52","author":"Pedersen","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.pupt.2005.10.008_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1183\/09031936.04.00076604","article-title":"Dose\u2013response relationship of inhaled budesonide in adult asthma: a meta-analysis","volume":"23","author":"Masoli","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0091-6749(03)01870-0","article-title":"Potential adverse effects of the inhaled corticosteroids","volume":"112","author":"Kelly","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(99)00019-4","article-title":"Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects","volume":"83","author":"Cave","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pupt.2005.10.008_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9343(99)80404-5","article-title":"Adverse effects of inhaled corticosteroids","volume":"98","author":"Hanania","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00128072-200305060-00001","article-title":"Inhaled corticosteroids in childhood asthma: long-term effects on growth and adrenocortical function","volume":"5","author":"Salvatoni","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.pupt.2005.10.008_bib19","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1378\/chest.124.6.2329","volume":"124","author":"Leone","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2005.10.008_bib20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/thx.54.1.7","article-title":"Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis","volume":"54","author":"van Grunsven","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2005.10.008_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/1054-139X(95)00231-G","article-title":"Chronic illness and emotional distress in adolescence","volume":"19","author":"Suris","year":"1996","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.pupt.2005.10.008_bib23","first-page":"501","article-title":"Medical care of the adolescent with asthma","volume":"11","author":"Howenstine","year":"2000","journal-title":"Adolesc Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpeds.2004.06.043","article-title":"Emotional quality-of-life and outcomes in adolescents with asthma","volume":"145","author":"Okelo","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.pupt.2005.10.008_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1378\/chest.113.3.587","article-title":"Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients","volume":"113","author":"Boulet","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2005.10.008_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/j.1552-4604.1997.tb04357.x","article-title":"Dependency of cortisol suppression on the administration time of inhaled corticosteroids [published correction appears in J Clin Pharmacol 1997; 37: 1000]","volume":"37","author":"Meibohm","year":"1997","journal-title":"J Clin Pharmacol"},{"issue":"Suppl. A","key":"10.1016\/j.pupt.2005.10.008_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0954-6111(05)80254-9","article-title":"Safety of high-dose inhaled corticosteroids","volume":"87","author":"Barnes","year":"1993","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/adc.87.6.457","article-title":"Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom","volume":"87","author":"Todd","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pupt.2005.10.008_bib29","first-page":"501s","article-title":"Unlicensed use of high-dose inhaled corticosteroids in the UK occurs principally with fluticasone\u2014an observational study of 26359 patients","volume":"24","author":"Thomas","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1203\/00006450-199701000-00007","article-title":"Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids","volume":"41","author":"Wolthers","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pupt.2005.10.008_bib31","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1210\/jc.85.2.652","article-title":"Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids","volume":"85","author":"Kannisto","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pupt.2005.10.008_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0954-6111(98)90039-7","article-title":"Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less","volume":"92","author":"Barnes","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/adc.2002.020560","article-title":"Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate","volume":"89","author":"Mahachoklertwattana","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pupt.2005.10.008_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1183\/09031936.03.00306302","article-title":"Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma","volume":"21","author":"Sim","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.2105013","article-title":"Systemic effect comparisons of six inhaled corticosteroid preparations","volume":"165","author":"Martin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib36","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/jc.2005-0036","article-title":"Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases","volume":"90","author":"Samaras","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pupt.2005.10.008_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1081-1206(10)62393-9","article-title":"Impaired recovery of hypothalamic\u2013pituitary\u2013adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler","volume":"88","author":"Kennedy","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1542\/peds.109.SE1.373","article-title":"Inhaled corticosteroid therapy for asthma in preschool children: growth issues","volume":"109","author":"Allen","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.pupt.2005.10.008_bib39","unstructured":"National Institutes of Health. National Heart, Lung and Blood Institute: Expert panel report: guidelines for the diagnosis and management of asthma: update on selected topics 2002. NIH Publication No. 02-5074, June 2003."},{"key":"10.1016\/j.pupt.2005.10.008_bib40","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1183\/09031936.97.10071507","article-title":"Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study","volume":"10","author":"Agertoft","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib41","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1542\/peds.109.3.e40","article-title":"Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma","volume":"109","author":"Anhoj","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.pupt.2005.10.008_bib42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1378\/chest.113.3.584","article-title":"Short-term growth in asthmatic children using fluticasone propionate","volume":"113","author":"Visser","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2005.10.008_bib43","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1542\/peds.113.2.e87","article-title":"Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1\u20133 years with recurrent wheezing","volume":"113","author":"Bisgaard","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.pupt.2005.10.008_bib44","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJM200010123431501","article-title":"Long-term effects of budesonide or nedocromil in children with asthma","volume":"343","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0091-6749(97)70072-1","article-title":"Attained adult height after childhood asthma: effect of glucocorticoid therapy","volume":"99","author":"Silverstein","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib46","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1056\/NEJM200010123431502","article-title":"Effect of long-term treatment with inhaled budesonide on adult height in children with asthma","volume":"343","author":"Agertoft","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0022-3476(99)70036-3","article-title":"Inhaled corticosteroids and growth velocity in children with asthma","volume":"135","author":"Purucker","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.pupt.2005.10.008_bib48","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.318.7194.1355","article-title":"Cushing's syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation","volume":"318","author":"Malozowski","year":"1999","journal-title":"Br Med J"},{"key":"10.1016\/j.pupt.2005.10.008_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1056\/NEJM200102223440812","article-title":"Asthma, corticosteroids, and growth","volume":"344","author":"Purucker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib50","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1258\/0007142001903535","article-title":"Heterogeneity of therapeutic responses in asthma","volume":"56","author":"Drazen","year":"2000","journal-title":"Br Med Bull"},{"key":"10.1016\/j.pupt.2005.10.008_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pupt.2004.04.005","article-title":"Potential genetic influences on the response to asthma treatment","volume":"17","author":"Pelaia","year":"2004","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2005.10.008_bib52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pupt.2005.10.008_bib53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pupt.2005.10.008_bib54","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1359\/jbmr.2000.15.6.1001","article-title":"Corticosteroids and fractures: a close encounter of the third cell kind","volume":"15","author":"Manolagas","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pupt.2005.10.008_bib55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00128072-200305070-00005","article-title":"Safety of the newer inhaled corticosteroids in childhood asthma","volume":"5","author":"Randell","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.pupt.2005.10.008_bib56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<188::AID-PPUL6>3.0.CO;2-K","article-title":"Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma","volume":"29","author":"Allen","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pupt.2005.10.008_bib57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-112-5-352","article-title":"Glucocorticoid-induced osteoporosis: pathogenesis and management","volume":"112","author":"Lukert","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ppul.1950200311","article-title":"Cross-sectional study of bone density in asthmatic children","volume":"20","author":"Hopp","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pupt.2005.10.008_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s001980050085","article-title":"Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate","volume":"8","author":"Gregson","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pupt.2005.10.008_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1542\/peds.114.2.469","article-title":"Inhaled corticosteroids and the risk of fractures in children and adolescents","volume":"114","author":"Schlienger","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.pupt.2005.10.008_bib61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.mop.0000129597.48138.e7","article-title":"Systemic effects of inhaled corticosteroids in children","volume":"16","author":"Allen","year":"2004","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.pupt.2005.10.008_bib62","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2105\/AJPH.85.12.1693","article-title":"Inhaled and oral corticosteroids: their effects on bone mineral density in older adults","volume":"85","author":"Marystone","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.pupt.2005.10.008_bib63","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/8756-3282(94)90309-3","article-title":"Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate","volume":"15","author":"Herrala","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.pupt.2005.10.008_bib64","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thx.47.6.414","article-title":"Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids","volume":"47","author":"Packe","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2005.10.008_bib65","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","article-title":"Inhaled corticosteroid use and bone-mineral density in patients with asthma","volume":"355","author":"Wong","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2005.10.008_bib66","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1164\/rccm.200310-1349OC","article-title":"Loss of bone density with inhaled triamcinolone in Lung Health Study II","volume":"170","author":"Scanlon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib67","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00198-003-1504-2","article-title":"Long-term fracture risk following adult-onset asthma: a population-based study","volume":"15","author":"Melton","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pupt.2005.10.008_bib68","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(93)91541-S","article-title":"Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids","volume":"342","author":"Simons","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2005.10.008_bib69","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0091-6749(93)90263-F","article-title":"Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma","volume":"91","author":"Toogood","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199707033370102","article-title":"Use of inhaled corticosteroids and the risk of cataracts","volume":"337","author":"Cumming","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib71","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/bjo.87.10.1247","article-title":"A population based case\u2013control study of cataract and inhaled corticosteroids","volume":"87","author":"Smeeth","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pupt.2005.10.008_bib72","first-page":"120","article-title":"Inhaled steroids: effect on intraocular pressure in patients without glaucoma","volume":"31","author":"Samiy","year":"1996","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.pupt.2005.10.008_bib73","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.277.9.722","article-title":"Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma","volume":"277","author":"Garbe","year":"1997","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.pupt.2005.10.008_bib74","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.300.6739.1548","article-title":"Purpura and dermal thinning associated with high dose inhaled corticosteroids","volume":"300","author":"Capewell","year":"1990","journal-title":"Br Med J"},{"key":"10.1016\/j.pupt.2005.10.008_bib75","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1183\/09031936.93.05091068","article-title":"Easy bruising as a side-effect of inhaled corticosteroids","volume":"5","author":"Mak","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib76","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1183\/09031936.96.09020226","article-title":"Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function","volume":"9","author":"Roy","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib77","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1164\/ajrccm.153.3.8630563","article-title":"Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo","volume":"153","author":"Autio","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib78","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","article-title":"Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease","volume":"340","author":"Pauwels","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib79","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1378\/chest.126.4.1123","article-title":"Skin manifestations of inhaled corticosteroids in COPD patients: results from Lung Health Study II","volume":"126","author":"Tashkin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2005.10.008_bib80","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thx.54.9.860","article-title":"Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma","volume":"54","author":"Fairfax","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2005.10.008_bib81","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM200008243430818","article-title":"Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone","volume":"343","author":"Leav","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib82","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1086\/341971","article-title":"Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy","volume":"35","author":"Peter","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pupt.2005.10.008_bib83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/02770909409056768","article-title":"Inhaled steroids and severe viral infections","volume":"31","author":"Welch","year":"1994","journal-title":"J Asthma"},{"key":"10.1016\/j.pupt.2005.10.008_bib84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00006454-200003000-00008","article-title":"Inhaled corticosteroid therapy is safe in tuberculin-positive asthmatic children","volume":"19","author":"Bahceciler","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pupt.2005.10.008_bib85","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ppul.10362","article-title":"Immune response to hepatitis B vaccine in asthmatic children","volume":"36","author":"Masten","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pupt.2005.10.008_bib86","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1542\/peds.112.2.e98","article-title":"A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles\u2013mumps\u2013rubella vaccination","volume":"112","author":"Verstraeten","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.pupt.2005.10.008_bib87","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2003.12.584","article-title":"Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy","volume":"113","author":"Hanania","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib88","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0149-2918(01)80113-2","article-title":"A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate","volume":"23","author":"Crim","year":"2001","journal-title":"Clin Ther"},{"issue":"Suppl. A","key":"10.1016\/j.pupt.2005.10.008_bib89","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0954-6111(97)90102-5","article-title":"Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety","volume":"91","author":"Derendorf","year":"1997","journal-title":"Respir Med"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2005.10.008_bib90","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1016\/S0091-6749(98)70156-3","article-title":"Pharmacokinetics and pharmacodynamics of inhaled corticosteroids","volume":"101","author":"Derendorf","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib91","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1177\/009127000004001107","article-title":"Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers","volume":"40","author":"Affrime","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2005.10.008_bib92","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2165\/00003495-200161090-00011","article-title":"Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma","volume":"61","author":"Sharpe","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2005.10.008_bib93","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/00003088-200443070-00004","article-title":"Pharmacokinetics of [14C] ciclesonide after oral and intravenous administration to healthy subjects","volume":"43","author":"Nave","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pupt.2005.10.008_bib94","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jps.20049","article-title":"Human receptor kinetics, tissue binding affinity, and stability of mometasone furoate","volume":"93","author":"Valotis","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pupt.2005.10.008_bib95","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0091270002250998","article-title":"Population pharmacokinetics and pharmacodynamics of ciclesonide","volume":"43","author":"Rohatagi","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2005.10.008_bib96","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1016\/S0091-6749(03)80757-1","article-title":"PK\/PD of inhaled corticosteroids: the risk\/benefit of inhaled ciclesonide","volume":"111","author":"Rohatagi","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib97","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/jpet.103.059592","article-title":"In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide","volume":"309","author":"Stoeck","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pupt.2005.10.008_bib98","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.98.12061346","article-title":"Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone","volume":"12","author":"Leach","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib99","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1378\/chest.122.2.510","article-title":"Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers","volume":"122","author":"Leach","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2005.10.008_bib100","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1183\/09031936.94.07101839","article-title":"Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI","volume":"7","author":"Thorsson","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib101","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0149-2918(00)83046-5","article-title":"Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler","volume":"22","author":"Pickering","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.pupt.2005.10.008_bib102","doi-asserted-by":"crossref","unstructured":"Newman S, Salmon A, Nave R, Drollman A. High lung deposition of 99mTc-labelled ciclesonide administered via HFA-MDI to patients with asthma. Respir Med, 2005, in press, doi:10.1016\/j.rmed.2005.09.027.","DOI":"10.1016\/j.rmed.2005.09.027"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2005.10.008_bib103","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0091-6749(03)01859-1","article-title":"Inhaled corticosteroids: past lessons and future issues","volume":"112","author":"Allen","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib104","first-page":"537","article-title":"Comparative potency and clinical efficacy of inhaled corticosteroids","volume":"5","author":"Kelly","year":"1999","journal-title":"Respir Care Clin North Am"},{"key":"10.1016\/j.pupt.2005.10.008_bib105","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1023\/A:1007591624451","article-title":"Metabolism kinetics of beclomethasone propionate esters in human lung homogenates","volume":"17","author":"Foe","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.pupt.2005.10.008_bib106","unstructured":"Colice GL, Derendorf H, Shapiro GG. Inhaled corticosteroids: is there an ideal therapy? [Medscape from WebMD Web site] Released February 20, 2004."},{"issue":"Suppl. 1","key":"10.1016\/j.pupt.2005.10.008_bib107","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/08942680150506303","article-title":"The influence of lung deposition on clinical response","volume":"14","author":"Pritchard","year":"2001","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib108","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s002280050407","article-title":"Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration","volume":"53","author":"Mollmann","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2005.10.008_bib109","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1378\/chest.120.6.1829","article-title":"Inhaled beclomethasone dipropionate improves acoustic measures of voice in patients with asthma","volume":"120","author":"Balter","year":"2001","journal-title":"Chest"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2005.10.008_bib110","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1016\/S0091-6749(99)70040-0","article-title":"The pharmacokinetics of inhaled hydrofluoroalkane formulations","volume":"104","author":"Borgstrom","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.pupt.2005.10.008_bib111","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1089\/08942680150506330","article-title":"Inhalation therapy of the future\u2014how will it change the way we treat asthma?","volume":"14","author":"Lotvall","year":"2001","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib112","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/j.1552-4604.1995.tb04064.x","article-title":"Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration","volume":"35","author":"Derendorf","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2005.10.008_bib113","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003495-199244030-00007","article-title":"Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis [published correction appears in Drugs 1992; 44: 1012 and Drugs 1993; 45: 1301]","volume":"44","author":"Brogden","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2005.10.008_bib114","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1980.54","article-title":"Flunisolide metabolism and dynamics of a metabolite","volume":"27","author":"Chaplin","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pupt.2005.10.008_bib115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00002018-200023010-00002","article-title":"Safety of inhaled and intranasal corticosteroids: lessons for the new millennium","volume":"23","author":"Lipworth","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.pupt.2005.10.008_bib116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1081\/JAS-120000802","article-title":"The antiinflammatory activity of budesonide on human airway epithelial cells is lasting after removal of the drug from cultures","volume":"39","author":"Sabatini","year":"2002","journal-title":"J Asthma"},{"key":"10.1016\/j.pupt.2005.10.008_bib117","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1081-1206(10)61893-5","article-title":"Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data","volume":"88","author":"Edsbacker","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib118","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1016\/S0021-9258(18)94054-8","article-title":"A comparison of the fatty acid esters of estradiol and corticosterone synthesized by tissues of the rat","volume":"264","author":"Pahuja","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pupt.2005.10.008_bib119","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0960-0760(91)90279-E","article-title":"Steroidal fatty acid esters","volume":"40","author":"Hochberg","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pupt.2005.10.008_bib120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1165\/ajrcmb.19.3.3195","article-title":"Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line In vitro","volume":"19","author":"Wieslander","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2005.10.008_bib121","first-page":"1311","article-title":"Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes","volume":"25","author":"Tunek","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pupt.2005.10.008_bib122","first-page":"623","article-title":"Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue","volume":"26","author":"Miller-Larsson","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pupt.2005.10.008_bib123","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pupt.2005.02.012","article-title":"Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide","volume":"18","author":"Nave","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2005.10.008_bib124","first-page":"86","article-title":"Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid","volume":"122","author":"Ryrfeldt","year":"1982","journal-title":"Eur J Respir Dis Suppl"},{"issue":"Suppl. 38","key":"10.1016\/j.pupt.2005.10.008_bib125","first-page":"109s","article-title":"Pharmacokinetics of 14C-ciclesonide after oral and intravenous administration in healthy subjects","volume":"20","author":"Nave","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib126","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1016\/j.bmc.2004.05.045","article-title":"Corticosteroids: the mainstay in asthma therapy","volume":"12","author":"Gupta","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pupt.2005.10.008_bib127","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2165\/00003495-199447020-00007","article-title":"Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma","volume":"47","author":"Holliday","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2005.10.008_bib128","doi-asserted-by":"crossref","unstructured":"Dietzel K, Engelst\u00e4tter R, Keller A. Ciclesonide: an on-site-activated steroid. In: Hansel TT, Barnes PJ, editors. New drugs for asthma, allergy and COPD. Basel, Switzerland: Karger. Progress in Respiratory Research 2001; 31: 91\u201393.","DOI":"10.1159\/000062132"},{"key":"10.1016\/j.pupt.2005.10.008_bib129","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1517\/13543784.13.10.1349","article-title":"Ciclesonide: a novel inhaled corticosteroid","volume":"13","author":"Humbert","year":"2004","journal-title":"Expert Opin Invest Drugs"},{"issue":"Suppl. 48","key":"10.1016\/j.pupt.2005.10.008_bib130","first-page":"346S","article-title":"In vitro modulation of the cytokine-induced human bronchial epithelial cell (HBEC) functions by ciclesonide (CIC)","volume":"24","author":"Serpero","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib131","doi-asserted-by":"crossref","unstructured":"Silvestri M, Serpero L, Petecchia L, Sabatini F, Cerasoli F, Rossi GA. Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide. Pulm Pharmacol Ther, 2005, in press, doi:10.1016\/j.pupt.2005.05.006.","DOI":"10.1016\/j.pupt.2005.05.006"},{"key":"10.1016\/j.pupt.2005.10.008_bib132","first-page":"201","article-title":"Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide","volume":"12","author":"Rohatagi","year":"2005","journal-title":"Am J Ther"},{"key":"10.1016\/j.pupt.2005.10.008_bib133","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00228-005-0910-0","article-title":"Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects","volume":"61","author":"Nave","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2005.10.008_bib134","first-page":"78","article-title":"Ciclesonide (Byk Gulden)","volume":"3","author":"Dent","year":"2002","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.pupt.2005.10.008_bib135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003495-200464050-00005","article-title":"Ciclesonide","volume":"64","author":"Reynolds","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2005.10.008_bib136","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1398-9995.2004.00750.x","article-title":"Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma","volume":"60","author":"Chapman","year":"2005","journal-title":"Allergy"},{"issue":"Suppl. 45","key":"10.1016\/j.pupt.2005.10.008_bib137","first-page":"410s","article-title":"Once daily ciclesonide (80 or 320\u03bcg) is equally effective as budesonide 200\u03bcg given twice daily: a 12-week study in asthma patients [abstract]","volume":"22","author":"Hansel","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib138","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pupt.2005.01.004","article-title":"Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5\u2032 monophosphate in asthmatic patients","volume":"18","author":"Derom","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"issue":"Suppl. 38","key":"10.1016\/j.pupt.2005.10.008_bib139","first-page":"373s","article-title":"Efficacy and long-term safety of ciclesonide in asthmatic patients as demonstrated in a 52 week long study","volume":"20","author":"Chapman","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1081-1206(10)61117-9","article-title":"Effect of ciclesonide and fluticasone on hypothalamic\u2013pituitary\u2013adrenal axis function in adults with mild-to-moderate persistent asthma","volume":"94","author":"Lipworth","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2005.10.008_bib141","article-title":"Once daily ciclesonide is as effective as fluticasone propionate given twice daily in treating patients with asthma","volume":"169","author":"Buhl","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2005.10.008_bib142","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1183\/09031936.01.00099701","article-title":"Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening","volume":"17","author":"Postma","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2005.10.008_bib143","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jaci.2004.12.037","article-title":"Once-daily treatment with ciclesonide is effective and well-tolerated in children with persistent asthma [abstract]","volume":"115","author":"Shapiro","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2005.10.008_bib144","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaci.2005.01.066","article-title":"Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide","volume":"115","author":"Agertoft","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2005.10.008_bib145","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.jaci.2003.12.397","article-title":"Ciclesonide has minimal oropharyngeal side effects in the treatment of patients with moderate-to-severe asthma","volume":"113","author":"Bernstein","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2005.10.008_bib146","article-title":"Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide: results from a pooled analysis [abstract]","volume":"169","author":"Engelst\u00e4tter","year":"2004","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455390500129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455390500129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T23:04:23Z","timestamp":1683327863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109455390500129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S109455390500129X"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2005.10.008","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}